Association of Disrupted in Schizophrenia 1 (DISC1) missense variants with ultra-resistant schizophrenia (original) (raw)

• Owen MJ, O Donovan MC, Gottesman II . Schizophrenia. In: McGuffin P, Owen MJ, Gottesman II (eds). Psychiatric Genetics and Genomics. Oxford University Press: Oxford, England, 2002; pp: 247–266.
  Google Scholar
• Conley RR, Kelly DL . Management of treatment resistance in schizophrenia. Biol Psychiatry 2001; 50: 898–911.
  Article CAS PubMed Google Scholar
• Essock SM, Hargreaves WA, Dohm FA, Goethe J, Carver L, Hipshman L . Clozapine eligibility among state hospital patients. Schizophr Bull 1996; 22: 15–25.
  Article CAS PubMed Google Scholar
• Davis JM, Casper R . Antipsychotic drugs: clinical pharmacology and therapeutic use. Drugs 1977; 14: 260–282.
  Article CAS PubMed Google Scholar
• Kane J, Honigfeld G, Singer J, Meltzer H . Clozapine for the treatment-resistant schizophrenic. A double-blind comparison with chlorpromazine. Arch Gen Psychiatry 1988; 45: 789–796.
  Article CAS PubMed Google Scholar
• Rosenheck R, Cramer J, Xu W, Thomas J, Henderson W, Frisman L et al. A comparison of clozapine and haloperidol in hospitalized patients with refractory schizophrenia. Department of Veterans Affairs Cooperative Study Group on Clozapine in Refractory Schizophrenia. N Engl J Med 1997; 337: 809–815.
  Article CAS PubMed Google Scholar
• Wahlbeck K, Cheine M, Essali A, Adams C . Evidence of clozapine's effectiveness in schizophrenia: a systematic review and meta-analysis of randomized trials. Am J Psychiatry 1999; 156: 990–999.
  CAS PubMed Google Scholar
• Hennen J, Baldessarini RJ . Suicidal risk during treatment with clozapine: a meta-analysis. Schizophr Res 2005; 73: 139–145.
  Article PubMed Google Scholar
• Buckley P, Miller A, Olsen J, Garver D, Miller DD, Csernansky J . When symptoms persist: clozapine augmentation strategies. Schizophr Bull 2001; 27: 615–628.
  Article CAS PubMed Google Scholar
• Mouaffak F, Tranulis C, Gourevitch R, Poirier MF, Douki S, Olie JP et al. Augmentation strategies of clozapine with antipsychotics in the treatment of ultraresistant schizophrenia. Clin Neuropharmacol 2006; 29: 28–33.
  Article CAS PubMed Google Scholar
• Elkis H . Treatment-resistant schizophrenia. Psychiatr Clin North Am 2007; 30: 511–533.
  Article PubMed Google Scholar
• Arranz MJ, de Leon J . Pharmacogenetics and pharmacogenomics of schizophrenia: a review of last decade of research. Mol Psychiatry 2007; 12: 707–747.
  Article CAS PubMed Google Scholar
• Anttila S, Illi A, Kampman O, Mattila KM, Lehtimaki T, Leinonen E . Interaction between NOTCH4 and catechol-O-methyltransferase genotypes in schizophrenia patients with poor response to typical neuroleptics. Pharmacogenetics 2004; 14: 303–307.
  Article CAS PubMed Google Scholar
• Hong CJ, Yu YW, Lin CH, Tsai SJ . An association study of a brain-derived neurotrophic factor Val66Met polymorphism and clozapine response of schizophrenic patients. Neurosci Lett 2003; 349: 206–208.
  Article CAS PubMed Google Scholar
• Krebs MO, Guillin O, Bourdell MC, Schwartz JC, Olie JP, Poirier MF et al. Brain derived neurotrophic factor (BDNF) gene variants association with age at onset and therapeutic response in schizophrenia. Mol Psychiatry 2000; 5: 558–562.
  Article CAS PubMed Google Scholar
• Kampman O, Anttila S, Illi A, Saarela M, Rontu R, Mattila KM et al. Neuregulin genotype and medication response in Finnish patients with schizophrenia. NeuroReport 2004; 15: 2517–2520.
  Article CAS PubMed Google Scholar
• Goldberger C, Gourion D, Leroy S, Schurhoff F, Bourdel MC, Leboyer M et al. Population-based and family-based association study of 5′UTR polymorphism of the reelin gene and schizophrenia. Am J Med Genet B Neuropsychiatr Genet 2005; 137B: 51–55.
  Article PubMed Google Scholar
• Taylor MS, Devon RS, Millar JK, Porteous DJ . Evolutionary constraints on the disrupted in schizophrenia locus. Genomics 2003; 81: 67–77.
  Article CAS PubMed Google Scholar
• Morris JA, Kandpal G, Ma L, Austin CP . DISC1 (Disrupted-In-Schizophrenia 1) is a centrosome-associated protein that interacts with MAP1A, MIPT3, ATF4/5 and NUDEL: regulation and loss of interaction with mutation. Hum Mol Genet 2003; 12: 1591–1608.
  Article CAS PubMed Google Scholar
• Chubb JE, Bradshaw NJ, Soares DC, Porteous DJ, Millar JK . The DISC locus in psychiatric illness. Mol Psychiatry 2008; 13: 36–64.
  Article CAS PubMed Google Scholar
• Kamiya A, Kubo K, Tomoda T, Takaki M, Youn R, Ozeki Y et al. A schizophrenia-associated mutation of DISC1 perturbs cerebral cortex development. Nat Cell Biol 2005; 7: 1167–1178.
  Article PubMed Google Scholar
• Ozeki Y, Tomoda T, Kleiderlein J, Kamiya A, Bord L, Fujii K et al. Disrupted-in-Schizophrenia-1 (DISC-1): mutant truncation prevents binding to NudE-like (NUDEL) and inhibits neurite outgrowth. Proc Natl Acad Sci USA 2003; 100: 289–294.
  Article CAS PubMed Google Scholar
• Mao Y, Ge X, Frank CL, Madison JM, Koehler AN, Doud MK et al. Disrupted in schizophrenia 1 regulates neuronal progenitor proliferation via modulation of GSK3beta/beta-catenin signaling. Cell 2009; 136: 1017–1031.
  Article CAS PubMed PubMed Central Google Scholar
• Kellendonk C, Simpson EH, Kandel ER . Modeling cognitive endophenotypes of schizophrenia in mice. Trends Neurosci 2009; 32: 347–358.
  Article CAS PubMed PubMed Central Google Scholar
• Niwa M, Kamiya A, Murai R, Kubo K, Gruber AJ, Tomita K et al. Knockdown of DISC1 by in utero gene transfer disturbs postnatal dopaminergic maturation in the frontal cortex and leads to adult behavioral deficits. Neuron 2010; 65: 480–489.
  Article CAS PubMed PubMed Central Google Scholar
• Millar JK, Wilson-Annan JC, Anderson S, Christie S, Taylor MS, Semple CA et al. Disruption of two novel genes by a translocation co-segregating with schizophrenia. Hum Mol Genet 2000; 9: 1415–1423.
  Article CAS PubMed Google Scholar
• Cannon TD, Hennah W, van Erp TG, Thompson PM, Lonnqvist J, Huttunen M et al. Association of DISC1/TRAX haplotypes with schizophrenia, reduced prefrontal gray matter, and impaired short- and long-term memory. Arch Gen Psychiatry 2005; 62: 1205–1213.
  Article CAS PubMed Google Scholar
• Hennah W, Tuulio-Henriksson A, Paunio T, Ekelund J, Varilo T, Partonen T et al. A haplotype within the DISC1 gene is associated with visual memory functions in families with a high density of schizophrenia. Mol Psychiatry 2005; 10: 1097–1103.
  Article CAS PubMed Google Scholar
• Callicott JH, Straub RE, Pezawas L, Egan MF, Mattay VS, Hariri AR et al. Variation in DISC1 affects hippocampal structure and function and increases risk for schizophrenia. Proc Natl Acad Sci USA 2005; 102: 8627–8632.
  Article CAS PubMed PubMed Central Google Scholar
• Hennah W, Varilo T, Kestila M, Paunio T, Arajarvi R, Haukka J et al. Haplotype transmission analysis provides evidence of association for DISC1 to schizophrenia and suggests sex-dependent effects. Hum Mol Genet 2003; 12: 3151–3159.
  Article CAS PubMed Google Scholar
• Hennah W, Porteous D . The DISC1 pathway modulates expression of neurodevelopmental, synaptogenic and sensory perception genes. PLoS One 2009; 4: e4906.
  Article PubMed PubMed Central Google Scholar
• Hodgkinson CA, Goldman D, Jaeger J, Persaud S, Kane JM, Lipsky RH et al. Disrupted in schizophrenia 1 (DISC1): association with schizophrenia, schizoaffective disorder, and bipolar disorder. Am J Hum Genet 2004; 75: 862–872.
  Article CAS PubMed PubMed Central Google Scholar
• Nurnberger Jr JI, Blehar MC, Kaufmann CA, York-Cooler C, Simpson SG, Harkavy-Friedman J et al. Diagnostic interview for genetic studies. Rationale, unique features, and training. NIMH Genetics Initiative. Arch Gen Psychiatry 1994; 51: 849–859, discussion 863–864.
  Article PubMed Google Scholar
• Ventura J, Lukoff D, Nuechterlein KH, Liberman RP, Green MFSA . Manual for the Expanded Brief Psychiatric Rating Scale. Int J Methods Psychiatr Res 1993; 3: 227–244.
  Google Scholar
• Ventura J, Green MF, Shaner A, Lieberman RP . Training and quality assurance with the brief psychiatric rating scale: the drift busters. Int J Methods Psychiatr Res 1993; 3: 221–244.
  Google Scholar
• Mouaffak F, Morvan Y, Bannour S, Chayet M, Bourdel MC, Thepaut G et al. Validation of the French version of the expanded Brief Psychiatric Rating Scale with anchor BPRS-E(A). Encephale 2009.
• Guy W . Clinical global impressions. In: Health NIoM (ed). ECDEU Assessment Manual for Psychopharmacology, revised. DHEW Publ Rockville: MD, 1976; pp 218–222.
  Google Scholar
• APA. Diagnostic and Statistical Manual of Mental Disorders, DSM-IV (4th ed). American Psychiatric Association: Washington DC, 1994.
• Kay SR, Fiszbein A, Opler LA . The positive and negative syndrome scale (PANSS) for schizophrenia. Schizophr Bull 1987; 13: 261–276.
  Article CAS PubMed Google Scholar
• Overall JE, Gorham D . The Brief Psychiatric Rating Scale (BPRS): recent developments in ascertainment and scaling. Psychopharmacol Bull 1988; 24: 97–99.
  Google Scholar
• Purcell S, Neale B, Todd-Brown K, Thomas L, Ferreira MA, Bender D et al. PLINK: a tool set for whole-genome association and population-based linkage analyses. Am J Hum Genet 2007; 81: 559–575.
  Article CAS PubMed PubMed Central Google Scholar
• Qu M, Tang F, Yue W, Ruan Y, Lu T, Liu Z et al. Positive association of the Disrupted-in-Schizophrenia-1 gene (DISC1) with schizophrenia in the Chinese Han population. Am J Med Genet B Neuropsychiatr Genet 2007; 144B: 266–270.
  Article CAS PubMed Google Scholar
• Song W, Li W, Feng J, Heston LL, Scaringe WA, Sommer SS . Identification of high risk DISC1 structural variants with a 2% attributable risk for schizophrenia. Biochem Biophys Res Commun 2008; 367: 700–706.
  Article CAS PubMed Google Scholar
• Betcheva ET, Mushiroda T, Takahashi A, Kubo M, Karachanak SK, Zaharieva IT et al. Case-control association study of 59 candidate genes reveals the DRD2 SNP rs6277 (C957T) as the only susceptibility factor for schizophrenia in the Bulgarian population. J Hum Genet 2009; 54: 98–107.
  Article CAS PubMed Google Scholar
• Harrow M, Grossman LS, Herbener ES, Davies EW . Ten-year outcome: patients with schizoaffective disorders, schizophrenia, affective disorders and mood-incongruent psychotic symptoms. Br J Psychiatry 2000; 177: 421–426.
  Article CAS PubMed Google Scholar
• Palo OM, Antila M, Silander K, Hennah W, Kilpinen H, Soronen P et al. Association of distinct allelic haplotypes of DISC1 with psychotic and bipolar spectrum disorders and with underlying cognitive impairments. Hum Mol Genet 2007; 16: 2517–2528.
  Article CAS PubMed Google Scholar
• Schumacher J, Laje G, Abou Jamra R, Becker T, Muhleisen TW, Vasilescu C et al. The DISC locus and schizophrenia: evidence from an association study in a central European sample and from a meta-analysis across different European populations. Hum Mol Genet 2009; 18: 2719–2727.
  Article CAS PubMed PubMed Central Google Scholar
• Kim HJ, Park HJ, Jung KH, Ban JY, Ra J, Kim JW et al. Association study of polymorphisms between DISC1 and schizophrenia in a Korean population. Neurosci Lett 2008; 430: 60–63.
  Article CAS PubMed Google Scholar
• Cipriani A, Boso M, Barbui C . Clozapine combined with different antipsychotic drugs for treatment resistant schizophrenia. Cochrane Database Syst Rev 2009; CD006324.
• Barbui C, Signoretti A, Mule S, Boso M, Cipriani A . Does the addition of a second antipsychotic drug improve clozapine treatment? Schizophr Bull 2009; 35: 458–468.
  Article PubMed Google Scholar
• Taylor DM, Smith L . Augmentation of clozapine with a second antipsychotic--a meta-analysis of randomized, placebo-controlled studies. Acta Psychiatr Scand 2009; 119: 419–425.
  Article CAS PubMed Google Scholar
• Takahashi T, Suzuki M, Tsunoda M, Maeno N, Kawasaki Y, Zhou SY et al. The Disrupted-in-Schizophrenia-1 Ser704Cys polymorphism and brain morphology in schizophrenia. Psychiatry Res 2009; 172: 128–135.
  Article CAS PubMed Google Scholar
• Clapcote SJ, Lipina TV, Millar JK, Mackie S, Christie S, Ogawa F et al. Behavioral phenotypes of Disc1 missense mutations in mice. Neuron 2007; 54: 387–402.
  Article CAS PubMed Google Scholar
• Laferriere NB, MacRae TH, Brown DL . Tubulin synthesis and assembly in differentiating neurons. Biochem Cell Biol 1997; 75: 103–117.
  Article CAS PubMed Google Scholar
• Harrison PJ . The neuropathological effects of antipsychotic drugs. Schizophr Res 1999; 40: 87–99.
  Article CAS PubMed Google Scholar
• Geerts H . AL-108 and AL-208, formulations of the neuroprotective NAP fragment of activity-dependent neuroprotective protein, for cognitive disorders. Curr Opin Investig Drugs 2008; 9: 800–811.
  CAS PubMed Google Scholar